NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-187-2015-0-AU-05 Compositions and Methods for the Treatment of HER2-Expressing Solid Tumors AU National Stage 2016343845 Issued
NCI E-187-2015-0-JP-04 Compositions and Methods for the Treatment of HER2-Expressing Solid Tumors JP National Stage 2018-521518 Issued
NCI E-187-2015-0-DE-08 Compositions and Methods for the Treatment of HER2-Expressing Solid Tumors DE EP 16795498.1 Issued
NCI E-187-2015-0-FR-09 Compositions and Methods for the Treatment of HER2-Expressing Solid Tumors FR EP 16795498.1 Issued
NCI E-187-2015-0-EP-06 Compositions and Methods for the Treatment of HER2-Expressing Solid Tumors EP National Stage 16795498.1 Issued
NCI E-187-2015-0-GB-10 Compositions and Methods for the Treatment of HER2-Expressing Solid Tumors GB EP 16795498.1 Issued
NIAID E-154-2010-1-US-04 CHIMPANZEE ADENOVIRAL VECTOR-BASED EILOVIRUS VACCINES US DIV 15/339,225 10584355 Issued PDF
NCI E-187-2015-0-PCT-02 Compositions and Methods for the Treatment of HER2-Expressing Solid Tumors PCT PCT PCT/US2016/059680 Expired
NCI E-187-2015-0-CA-03 Compositions and Methods for the Treatment of HER2-Expressing Solid Tumors CA National Stage 3002685 Pending
NIBIB E-079-2011-1-US-03 Imaging Agents For Imaging Protease Activity And Uses Thereof US DIV 15/337,461 10646591 Abandoned PDF
NCI E-109-2016-0-PCT-02 TARGETED CANCER THERAPY PCT PCT PCT/US2016/059452 Expired
NCI E-108-2016-0-PCT-02 TARGETED CANCER THERAPY PCT PCT PCT/US2016/059388 Expired
NCI E-109-2016-0-HK-13 TARGETED CANCER THERAPY HK EP 19101252.0 Pending
NCI E-109-2016-0-CN-07 TARGETED CANCER THERAPY CN National Stage 201680077320.4 Abandoned
NCI E-109-2016-0-EP-08 TARGETED CANCER THERAPY EP National Stage 16860932.9 Abandoned
NCI E-188-2016-0-US-01 Stable Water Isotope Labeling and Magnetic Resonance Imaging for Visualization of Rapidly Dividing Cells US 62/414,554 Abandoned
NCI E-109-2016-0-CA-06 TARGETED CANCER THERAPY CA National Stage 3003728 Abandoned
NCI E-109-2016-0-MX-12 TARGETED CANCER THERAPY MX National Stage MX/A/2018/005468 Pending
NCI E-109-2016-0-KR-11 TARGETED CANCER THERAPY KR National Stage 10-2018-7014629 Pending
NCI E-109-2016-0-AU-04 TARGETED CANCER THERAPY AU National Stage 2016343722 Abandoned
NCI E-109-2016-0-BR-05 TARGETED CANCER THERAPY BR National Stage BR112018008783-1 Abandoned
NCI E-109-2016-0-IL-09 TARGETED CANCER THERAPY IL National Stage 259017 Abandoned
NIAID E-043-2011-0-JP-16 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines JP DIV 2016-206679 Issued
NCI E-173-2018-0-US-01 Genetically Modified Cells US 62/413,814 Abandoned
NCI E-294-2010-1-US-02 PHARMACEUTICAL COMPOSITION COMPRISING NANOG SHRNA, AND METHOD OF USING NANOG SHRNA TO TREAT CANCER US CON 15/334,666 9988631 Issued PDF
NIAID E-052-2017-0-TW-06 Trispecific Binding Protein TW ORD 105134405 Abandoned
NIAID E-052-2017-0-AR-02 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR PREVENTION OR TREATMENT OF HIV INFECTION AR ORD 20160103249 Abandoned
NIAID E-052-2017-0-UY-07 Trispecific Binding Protein UY ORD 36.965 Abandoned
NIAID E-052-2017-0-VE-08 Trispecific Binding Protein VE ORD 501-16 Abandoned
NIAID E-234-2016-0-US-01 Prefusion Coronavirus Spike Proteins And Their Use US 62/412,703 Abandoned
NIAID E-215-2016-0-US-01 Prefusion HPIV F Immunogens and their use US 62/412,699 Abandoned
NCI E-283-2016-0-US-01 IL-6 And IL-17A As Classifiers Of Lung Cancer Mortality For Stage I Adenocarcinoma US 62/412,690 Abandoned
NHLBI E-045-2018-0-US-01 Vascular Anchoring Introducer Sheath US 62/412,646 Abandoned
NIAID E-052-2017-0-GC-03 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR PREVENTION OR TREATMENT OF HIV INFECTION GC ORD 2016/32243 Abandoned
NIAID E-052-2017-0-GC-11 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR PREVENTION OR TREATMENT OF HIV
INFECTION 		GC DIV 2016/40021 Pending
NIAID E-052-2017-0-BO-10 Trispecific Binding Protein BW ORD SP 00245-2016 Abandoned
NIAID E-052-2017-0-PY-09 Trispecific Binding Protein PY ORD 69554/2016 Abandoned
NIAID E-052-2017-0-LB-04 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR PREVENTION OR TREATMENT OF HIV INFECTION LB ORD 20160019275 Abandoned
NIAID E-052-2017-4-VN-15 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection VN National Stage 1-2018-02233 Abandoned
NIAID E-052-2017-4-AU-18 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection AU National Stage 2016347058 Abandoned
NIAID E-052-2017-4-IN-32 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection IN National Stage 201817019369 Abandoned
NIAID E-052-2017-4-CN-17 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection CN National Stage 201680075852.4 Abandoned
NIAID E-052-2017-4-MX-36 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection MX National Stage MX/a/2018/005048 Abandoned
NIAID E-052-2017-4-JP-33 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection JP National Stage 2018-521308 Abandoned
NIAID E-052-2017-4-MY-37 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection MY National Stage PI 2018701634 Abandoned
NIAID E-052-2017-4-EA-12 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection EA National Stage 201891028 Abandoned
NIAID E-052-2017-4-HK-29 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection HK National Stage 18112682.8 Abandoned
NIAID E-052-2017-4-DE-62 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR PREVENTION OR TREATMENT OF HIV INFECTION DE EP 16794472.7 Abandoned
NIAID E-052-2017-4-IE-72 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR PREVENTION OR TREATMENT OF HIV INFECTION IE EP 16794472.7 Abandoned
NIAID E-052-2017-4-GR-69 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR PREVENTION OR TREATMENT OF HIV INFECTION GR EP 16794472.7 Abandoned